Dexterit-E 3.6 has been a monumental effort for the team at BKIN and we are very proud of what we’ve been able to accomplish in this “landmark” release.
The camp was held June 5 – 10 , 2016 in Kingston, Ontario on the beautiful campus of Queen’s University.
Over a period of 5 days, 12 Campers from 10 different sites, received in-depth training on Custom Task development for KINARM Labs.
Here’s what this year’s campers said about Camp:
A customer of ours recently asked us to undertake an interesting challenge: create a custom KINARM Lab that enabled two KINARM End-Point robots, with Virtual Reality, to interact with each other in real time. The BKIN team was up to the challenge and want to share the result!
The classic Scott KINARM was great, but now it is even better…
Vertical out-of-plane stiffness: 8,500 N/m
End-point in-plane mechanical stiffness: ~16,400 N/m
• Greater Accessibility to the Head: The motors are mounted below the shoulders thus enabling full access to the head. Now you can use TMS – and any other head-mounted peripheral – without having to “squeeze it in”.
• No More Analog: The electronics have been upgraded to all digital communication using the EtherCAT protocol.
• Quiet and Smooth: With EtherCAT, we’ve changed the servo amps, eliminating the audible noise and slight jitter felt with the Classic. Subjects perceive smoother movements.
The NEW KINARM Exoskeleton is now generally available. Contact: firstname.lastname@example.org for more information and pricing.
Download the KINARM Exoskeleton’s New Look
KINGSTON, ON — BKIN Technologies Ltd. is pleased to announce that its KINARM robotic assessment system has been granted three additional patents.
Three separate patent families had patents issued or allowed since the beginning of the year, in part thanks to the expert stewardship of the patent group at PARTEQ Innovations. “Method and Apparatus for Assessing or Detecting Brain Injury and Neurological Disorders” (US Patent No. 8,740,794) issued on June 3, 2014 which covers two foundational tasks in BKIN’s KINARM Standard Tests suite.
Move brings manufacturing together with design and development teams
A dream long held by the BKIN team was finally realized today when the group completed their move to a new off-campus location on Railway St. Just off Division St., in the heart of Kingston, the area allows the team to keep close physical proximity to their founder and collaborators at Queen’s University, while giving the team the “three-in-one” space that they needed: design, manufacturing and machining all under one roof in an affordable footprint.
KINGSTON, ON — BKIN Technologies Ltd. is pleased to announce that its KINARM™ robotic assessment system has been granted three patents.
Two patents, for “Method and Apparatus for Assessing Proprioceptive Function,” were granted by patent offices of China and the United States, respectively. The patents relate to the KINARM’s method and apparatus for detecting, quantifying, and/or treating impairments in processing sensory information relating to limb movements and motor control. A U.S. patent was also issued for “Robotic Exoskeleton for Limb Movement.”
The on-line newsletter of the Ontario Brain Institute has profiled a collaborative project made possible by the partnership between the Ontario Brain Institute and the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), through the Technology Development Program. Allergan Canada Inc. (maker of BOTOX®) and BKIN Technologies Ltd. provided substantial in-kind and cash funding to enable this support.
Sunnybrook Research Institute also profiled the project.
BKIN Technologies Ltd. is pleased to announce that Dr. Stephen Scott, BKIN’s Chief Scientific Officer and inventor of its flagship technology, KINARM, has received two major awards for his pioneering research into understanding brain function and measuring the effects of brain injury.
Dr. Scott has been named Queen’s University’s first GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR) Chair in Neurosciences. The award enables him to continue his world-leading research into understanding brain function while at the same time translating his findings into real-world clinical tools.